Moderna signs agreement to supply Qatar with mRNA COVID-19 vaccine
American biotech Moderna has signed an agreement with the Ministry of Public Health to supply Qatar with its mRNA COVID-19
Read more
COVID-19
Coronavirus (COVID-19) pharmaceutical industry updates
Read the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
AstraZeneca receives FDA authorisation to resume COVID-19 vaccine trial
AstraZeneca has confirmed that the U.S. FDA has authorised the resumption of Phase III clinical trials of the COVID-19 AZD1222
Read more
SYNLAB validates saliva sampling method for SARS-CoV-2 testing
SYNLAB, leading European provider of medical diagnostic solutions, has revealed the successful authorization of saliva sampling platform, another groundbreaking non-invasive
Read more
The Acceleration of Digitalisation in Pharma in 2020
This year, more than ever has required the pharma industry to dive into digitalisation in all shapes and forms. With
Read more
Donald Trump treated with experimental Monoclonal Antibody cocktail
United States President Donald Trump has been administered with an intravenous dose of Regeneron Pharmaceuticals experimental COVID-19 treatment REGN-COV2, a
Read more
New analysis proposes Severe COVID-19 is a Microvascular Disease
The range of clinical responses to SARS-CoV-2 infection is extremely broad, a factor making the disease particularly difficult to properly
Read more
J&J Covid-19 Vaccine produces a strong neutralizing antibody response
Interim analysis of the J&J COVID-19 vaccine candidate (JNJ-78436735) in the ongoing Phase 1/2a clinical trial has shown that a
Read more
GMP Certified mRNA Manufacturing Site, BioNTech, Marburg, Germany
Next-gen immunotherapy company BioNTech announced this month the completion of a share purchase agreement with Swiss pharma giant Novartis AG,
Read more
Oxford & AstraZeneca pause COVID-19 trial as participant falls ill
Phase 3 clinical trials for the COVID-19 vaccine named AZD1222, developed by AstraZeneca and Oxford University, have been paused after
Read more
Lilly starts Phase 3 Trial of monoclonal antibody for COVID-19 prevention
Eli Lilly and Company announced the start of BLAZE-2, a Phase 3 study of the monoclonal antibody LY-CoV555 vaccine candidate
Read more